| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| MousePheno | increased susceptibility to Togaviridae infection | 3.31e-05 | 3 | 47 | 2 | MP:0020940 | |
| Domain | C2H2_Znf_fam | 2.50e-03 | 24 | 58 | 2 | IPR027775 | |
| Domain | FHA_DOMAIN | 4.16e-03 | 31 | 58 | 2 | PS50006 | |
| Domain | FHA_dom | 5.58e-03 | 36 | 58 | 2 | IPR000253 | |
| Domain | - | 5.58e-03 | 36 | 58 | 2 | 2.60.200.20 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | CCHCR1 RANBP2 COPZ1 CENPE PHF12 MORC3 EMSY ERLIN1 USP47 VCPIP1 | 2.54e-06 | 853 | 62 | 10 | 28718761 |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 2.81e-06 | 123 | 62 | 5 | 26912792 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 9.04e-06 | 774 | 62 | 9 | 15302935 | |
| Pubmed | ZC3H14 RANBP2 DST COPZ1 PHF12 MDC1 HIP1R CDC42BPB KIF20B EMSY ZMYM3 ERLIN1 | 1.13e-05 | 1497 | 62 | 12 | 31527615 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.23e-05 | 608 | 62 | 8 | 36089195 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 18314909 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 34963055 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RANBP2 DST MDC1 RSF1 HIP1R PSMD7 RIOK2 KIF20B ZMYM3 ERLIN1 RASAL2 | 2.43e-05 | 1353 | 62 | 11 | 29467282 |
| Pubmed | DST NBEA PSMD7 NCAPH2 MORC3 USPL1 CDC42BPB RASAL2 USP47 VCPIP1 | 8.56e-05 | 1285 | 62 | 10 | 35914814 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 9.07e-05 | 1294 | 62 | 10 | 30804502 | |
| Pubmed | 1.01e-04 | 418 | 62 | 6 | 34709266 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CCHCR1 RNF214 COPZ1 ARHGAP26 PTPRQ PSMD7 NCAPH2 MORC3 ERLIN1 RASAL2 | 1.08e-04 | 1321 | 62 | 10 | 27173435 |
| Pubmed | 1.39e-04 | 638 | 62 | 7 | 31182584 | ||
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 1.53e-04 | 150 | 62 | 4 | 28242625 | |
| Pubmed | 1.57e-04 | 453 | 62 | 6 | 29656893 | ||
| Pubmed | 1.60e-04 | 653 | 62 | 7 | 22586326 | ||
| Pubmed | 1.89e-04 | 469 | 62 | 6 | 27634302 | ||
| Pubmed | 2.04e-04 | 1429 | 62 | 10 | 35140242 | ||
| Pubmed | Sequence and expression of murine type I hair keratins mHa2 and mHa3. | 2.81e-04 | 14 | 62 | 2 | 7514534 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 3.19e-04 | 332 | 62 | 5 | 32786267 | |
| Pubmed | 3.20e-04 | 74 | 62 | 3 | 29795351 | ||
| Pubmed | Regulation of the Mdm2-p53 pathway by the ubiquitin E3 ligase MARCH7. | 3.23e-04 | 15 | 62 | 2 | 29295817 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 4.11e-04 | 351 | 62 | 5 | 38297188 | |
| Pubmed | 4.58e-04 | 777 | 62 | 7 | 35844135 | ||
| Pubmed | 4.97e-04 | 86 | 62 | 3 | 37253089 | ||
| Pubmed | A year of COVID-19 GWAS results from the GRASP portal reveals potential genetic risk factors. | 5.82e-04 | 20 | 62 | 2 | 35224516 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 6.27e-04 | 588 | 62 | 6 | 38580884 | |
| Pubmed | 6.64e-04 | 95 | 62 | 3 | 24029230 | ||
| Pubmed | 6.74e-04 | 222 | 62 | 4 | 37071664 | ||
| Pubmed | 7.09e-04 | 225 | 62 | 4 | 12168954 | ||
| Pubmed | 7.34e-04 | 606 | 62 | 6 | 36538041 | ||
| Pubmed | 7.49e-04 | 99 | 62 | 3 | 27746211 | ||
| Pubmed | mTOR drives its own activation via SCF(βTrCP)-dependent degradation of the mTOR inhibitor DEPTOR. | 7.72e-04 | 23 | 62 | 2 | 22017875 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 8.37e-04 | 411 | 62 | 5 | 35182466 | |
| Pubmed | 9.89e-04 | 26 | 62 | 2 | 26857994 | ||
| Pubmed | 1.00e-03 | 247 | 62 | 4 | 30713523 | ||
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | 1.05e-03 | 432 | 62 | 5 | 23455922 | |
| Pubmed | 1.07e-03 | 27 | 62 | 2 | 21343306 | ||
| Pubmed | 1.18e-03 | 116 | 62 | 3 | 21282530 | ||
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 1.25e-03 | 262 | 62 | 4 | 36880596 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | 1.27e-03 | 925 | 62 | 7 | 28986522 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 1.29e-03 | 1203 | 62 | 8 | 29180619 | |
| Pubmed | 1.32e-03 | 30 | 62 | 2 | 31740976 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 1.34e-03 | 934 | 62 | 7 | 33916271 | |
| Pubmed | Essential roles for the splicing regulator nSR100/SRRM4 during nervous system development. | 1.41e-03 | 31 | 62 | 2 | 25838543 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 1.51e-03 | 954 | 62 | 7 | 36373674 | |
| Pubmed | Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligase. | 1.57e-03 | 128 | 62 | 3 | 25332235 | |
| Pubmed | 1.60e-03 | 963 | 62 | 7 | 28671696 | ||
| Pubmed | 1.67e-03 | 284 | 62 | 4 | 29459677 | ||
| Pubmed | 1.68e-03 | 481 | 62 | 5 | 28190767 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | 1.70e-03 | 974 | 62 | 7 | 28675297 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q25 | 1.53e-03 | 167 | 62 | 3 | chr1q25 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 3.43e-04 | 12 | 42 | 2 | 1243 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | RANBP2 DST CENPE MDC1 RSF1 EFCAB14 MORC3 RIOK2 KIF20B ZNF518A | 8.26e-07 | 469 | 61 | 10 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 8.33e-06 | 255 | 61 | 7 | Facebase_RNAseq_e10.5_Maxillary Arch_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_100 | 1.01e-05 | 100 | 61 | 5 | Facebase_RNAseq_e10.5_Mandibular Arch_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 3.15e-05 | 432 | 61 | 8 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | CENPE ARHGAP26 MDC1 IRAK1BP1 NBEA TRPM1 SCARA3 KIF20B ZMYM3 FILIP1L | 4.70e-05 | 744 | 61 | 10 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500 | 7.87e-05 | 492 | 61 | 8 | Facebase_RNAseq_e10.5_Maxillary Arch_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.82e-04 | 98 | 61 | 4 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_1000 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_500 | 1.96e-04 | 294 | 61 | 6 | gudmap_kidney_P0_CapMes_Crym_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.11e-04 | 298 | 61 | 6 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | ANGPT1 ARHGAP26 IRAK1BP1 NBEA TRPM1 MUC4 SCARA3 ZMYM3 FILIP1L | 2.15e-04 | 726 | 61 | 9 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | ANGPT1 ARHGAP26 IRAK1BP1 NBEA TRPM1 MUC4 SCARA3 ZMYM3 FILIP1L | 2.33e-04 | 734 | 61 | 9 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K5 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.83e-04 | 110 | 61 | 4 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | HMCN1 ARHGAP26 PHTF2 MORC3 RASAL2 SMC1B ZNF518A VCPIP1 IFNAR1 | 3.51e-04 | 776 | 61 | 9 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | 3.57e-04 | 778 | 61 | 9 | gudmap_developingGonad_e18.5_ovary_1000 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.96e-06 | 185 | 62 | 5 | e06a784a297f357f3f8e761c24fa70722048ab42 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.96e-06 | 191 | 62 | 5 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.08e-06 | 197 | 62 | 5 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.08e-06 | 197 | 62 | 5 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.49e-06 | 199 | 62 | 5 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.49e-06 | 199 | 62 | 5 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.70e-06 | 200 | 62 | 5 | 251fd2923f108cd2086961d897244b392c32ad54 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Vcan_(SNc)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.47e-05 | 61 | 62 | 3 | 12de8c495c7f47ecd720f29a573471705603732a | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Vcan_(SNc)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.47e-05 | 61 | 62 | 3 | a655232c6d92335eb086723ab9b05eb3a5479b68 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.04e-05 | 169 | 62 | 4 | 6614c9851537e4c21b1e45ff0cc3bad07ef9d034 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.04e-05 | 169 | 62 | 4 | 665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.46e-05 | 171 | 62 | 4 | 121e63ca281ad765d76c2afb3b4d441329b47f81 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.68e-05 | 172 | 62 | 4 | eba1568d4307e91c94fc616549057cbed8df5840 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-05 | 173 | 62 | 4 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-05 | 173 | 62 | 4 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-05 | 173 | 62 | 4 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 174 | 62 | 4 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.03e-04 | 175 | 62 | 4 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 175 | 62 | 4 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-04 | 175 | 62 | 4 | 3e56695a9db97cb1d3503425c48eb79bbf99213e | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-04 | 175 | 62 | 4 | d43ae33a6256606ce848247cad32d74f21b38988 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-04 | 177 | 62 | 4 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-04 | 177 | 62 | 4 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-04 | 178 | 62 | 4 | 8b939659f713eea50a1a6e28b571f680ca0b4c12 | |
| ToppCell | MS-Treg-naive_CD4|MS / Condition, Cell_class and T cell subcluster | 1.15e-04 | 180 | 62 | 4 | 7ca083616926d98420fa11a6e5ebc981623f79ac | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-04 | 181 | 62 | 4 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.28e-04 | 185 | 62 | 4 | c85bba1210f1d389add3e40be9b96abac40cf8c1 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_NK-Cycling_NK|GI_small-bowel / Manually curated celltypes from each tissue | 1.34e-04 | 187 | 62 | 4 | 265c690c2921fd201361a0ec8bc4d2a996fbcaf4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-04 | 187 | 62 | 4 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-04 | 187 | 62 | 4 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.34e-04 | 187 | 62 | 4 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.36e-04 | 188 | 62 | 4 | 6c6486cae9a8f2f8200598cb4bfd3fd513eb28a3 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-leukocyte-proliferating_myeloid_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.36e-04 | 188 | 62 | 4 | 797ce39602f0f78081eb44a21da0d9443f7fd9cf | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-leukocyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.36e-04 | 188 | 62 | 4 | 61b6047affa18c5e71210fcce449e2bbe7cf141b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.39e-04 | 189 | 62 | 4 | 284f39dfacec76004daae9dd5317fb7b1f04fa99 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 189 | 62 | 4 | 6b3b42d758b63a0df62310c34fa3bde421c1afd7 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 189 | 62 | 4 | 344b23d3c47d0665dda1cd4856a5e72f1c28cfb3 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Control / Disease state, Lineage and Cell class | 1.39e-04 | 189 | 62 | 4 | 937e876122bc4b94372a4104e9c1a9068c232018 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.42e-04 | 190 | 62 | 4 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-04 | 191 | 62 | 4 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.45e-04 | 191 | 62 | 4 | 24dc77ee8de01b42559f92721655f4281b114e17 | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.45e-04 | 191 | 62 | 4 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.45e-04 | 191 | 62 | 4 | b51e0f5d1b93f526160c904e9091313a5364f3a7 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 1.45e-04 | 191 | 62 | 4 | a7bb8aba9c59c037d995a77928cc7b4d5cbb82b9 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-04 | 191 | 62 | 4 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | Mild-T/NK_proliferative|World / Disease group and Cell class | 1.45e-04 | 191 | 62 | 4 | 9dba5526fd5ea8065ad305feb2ee562335f887c6 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.45e-04 | 191 | 62 | 4 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.45e-04 | 191 | 62 | 4 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.48e-04 | 192 | 62 | 4 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 192 | 62 | 4 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 192 | 62 | 4 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 192 | 62 | 4 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 192 | 62 | 4 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 192 | 62 | 4 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.48e-04 | 192 | 62 | 4 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.51e-04 | 193 | 62 | 4 | 9d0b966d13cbce97beb43de6dc77f006c363a181 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.51e-04 | 193 | 62 | 4 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-04 | 194 | 62 | 4 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-04 | 194 | 62 | 4 | 8fae8061b350336299aa81f378e07deadbd55123 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-04 | 194 | 62 | 4 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 194 | 62 | 4 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-04 | 194 | 62 | 4 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 194 | 62 | 4 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-04 | 194 | 62 | 4 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-04 | 194 | 62 | 4 | 4d7d24390fdb379f943ddcc70a63f23955e10163 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Neuronal-Glial_mature-Adult_Glia|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 194 | 62 | 4 | d429bb5e422a07bd92f0dc48cd51528e8b7d9a72 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Neuronal|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 194 | 62 | 4 | bffdf6db0bf3fb338e7bb0789ae7dcde1fce0094 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Neuronal-Glial_mature|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 194 | 62 | 4 | 408dfc7060095972a54ae37ae8105521df6fbbee | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.57e-04 | 195 | 62 | 4 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 1.60e-04 | 196 | 62 | 4 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 1.60e-04 | 196 | 62 | 4 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.60e-04 | 196 | 62 | 4 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.60e-04 | 196 | 62 | 4 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.60e-04 | 196 | 62 | 4 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-04 | 197 | 62 | 4 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.63e-04 | 197 | 62 | 4 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.63e-04 | 197 | 62 | 4 | b2f4d7c301c0b24003374923b31d6d058e40b213 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.63e-04 | 197 | 62 | 4 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|normal_Lung / Location, Cell class and cell subclass | 1.63e-04 | 197 | 62 | 4 | 6c57ab2efb8363828e24211c4d45e58bb73a9a4d | |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.66e-04 | 198 | 62 | 4 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.66e-04 | 198 | 62 | 4 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.66e-04 | 198 | 62 | 4 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.66e-04 | 198 | 62 | 4 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.66e-04 | 198 | 62 | 4 | 8afeb1f9bc9d8551482c8fefe4c5f88d9cd13ee2 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.66e-04 | 198 | 62 | 4 | a9afedbc0556faf4a46f7bf28f4a9adb3bc859d8 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.66e-04 | 198 | 62 | 4 | 7b5350768f306ec528e271d2ac4470bf668ec6f0 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.66e-04 | 198 | 62 | 4 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.66e-04 | 198 | 62 | 4 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.66e-04 | 198 | 62 | 4 | da6963184c32761c896a9b91a5321ad84b583736 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.69e-04 | 199 | 62 | 4 | 7f4840ae6a888380feca722543e5e52783f3e35d | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.69e-04 | 199 | 62 | 4 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.69e-04 | 199 | 62 | 4 | fb23ecce41e31e2cc01814e3c0add756f489561f | |
| ToppCell | proximal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.69e-04 | 199 | 62 | 4 | 301d02bbb37e6f1d24b6e865bc3fe3e91260eb30 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.69e-04 | 199 | 62 | 4 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.69e-04 | 199 | 62 | 4 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.69e-04 | 199 | 62 | 4 | 38ed3bc7daa993d9edcf3e7834597ebb06dd24f8 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.69e-04 | 199 | 62 | 4 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.69e-04 | 199 | 62 | 4 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.69e-04 | 199 | 62 | 4 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.69e-04 | 199 | 62 | 4 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| Drug | 0173570-0000 [211245-44-2]; Down 200; 10uM; PC3; HT_HG-U133A | 9.56e-06 | 183 | 61 | 6 | 7389_DN | |
| Drug | Oxamniquine [21738-42-1]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 1.22e-05 | 191 | 61 | 6 | 4124_DN | |
| Drug | Vitexin [3681-93-4]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.37e-05 | 195 | 61 | 6 | 2810_DN | |
| Disease | lung carcinoma (is_marker_for) | 4.05e-05 | 5 | 60 | 2 | DOID:3905 (is_marker_for) | |
| Disease | colorectal cancer, hormone replacement therapy | 7.76e-04 | 88 | 60 | 3 | EFO_0003961, MONDO_0005575 | |
| Disease | respiratory failure, COVID-19 | 1.59e-03 | 29 | 60 | 2 | EFO_0009686, MONDO_0100096 | |
| Disease | Huntington disease, disease progression measurement | 1.71e-03 | 30 | 60 | 2 | EFO_0008336, MONDO_0007739 | |
| Disease | cerebrospinal fluid clusterin measurement | 2.32e-03 | 35 | 60 | 2 | EFO_0007657 | |
| Disease | colonic neoplasm | 3.17e-03 | 41 | 60 | 2 | EFO_0004288 | |
| Disease | Influenza | 5.05e-03 | 52 | 60 | 2 | C0021400 | |
| Disease | susceptibility to common cold measurement | 5.44e-03 | 54 | 60 | 2 | EFO_0008417 | |
| Disease | obsolete_red blood cell distribution width | 5.73e-03 | 1347 | 60 | 8 | EFO_0005192 | |
| Disease | narcolepsy-cataplexy syndrome | 6.46e-03 | 59 | 60 | 2 | MONDO_0016158 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VSQTTATQEKSQEEL | 606 | Q8N7X0 | |
| TTGQVSSRSRVQVQK | 206 | Q9BWW8 | |
| FRSVQTTLQTDEVKN | 61 | O75477 | |
| SQTAEQTRKLTDVET | 136 | Q15389 | |
| QTRGDDTDQQKTTVI | 21 | P56179 | |
| SLDQVTNRTDTVKIQ | 341 | O75071 | |
| QEAQKSQTEEITSTT | 2761 | P49792 | |
| TRTEKTAQVTVQDSQ | 1276 | P20742 | |
| QTQSVETTRVSQINT | 326 | Q99102 | |
| NNVSVIQVTTRTRKS | 481 | Q13127 | |
| VQDERDVQSQSSSTI | 36 | O75409 | |
| LSSTQAQTATREVQV | 41 | Q5VVH5 | |
| ERSQASTTVDINTQV | 511 | Q14676 | |
| VQESVTTQVERLETQ | 3611 | Q03001 | |
| ENISTIATVEETNQT | 506 | P17181 | |
| TEVEQLKSTNQQTAT | 856 | Q14149 | |
| EQESQASAVTVTRDK | 391 | Q8IXI2 | |
| NEIETATRSITNNVS | 966 | Q96Q89 | |
| TEQTVSQVLQSAKEQ | 156 | P61923 | |
| TQVASIKQLRETQST | 741 | Q9UJF2 | |
| NVKVSNAQSVTSERE | 461 | O60669 | |
| ELSRKLQESTQTVQS | 456 | Q9Y5S2 | |
| KDNVQVTESSTIQTV | 1396 | Q96RW7 | |
| EERTINTTSLTQNIK | 846 | Q9UMZ3 | |
| TAKQLTVTQQSQEEV | 471 | O75146 | |
| QNTVTTGIVSTAQRE | 266 | P83110 | |
| ASSQLQVEQNKVTTV | 521 | Q4L180 | |
| VISQGQTSNVTDNRK | 496 | Q6ZRK6 | |
| QTSNVTDNRKSVTTE | 501 | Q6ZRK6 | |
| VASLQEKVTSQSQEQ | 366 | Q8TD31 | |
| QVSQTTEVLTTRIKE | 126 | Q8N1E2 | |
| VATQKAETQRSSIEV | 126 | Q587J8 | |
| TQVSRSRKQSEELQS | 26 | Q9BU64 | |
| QATVVSEQTRQLVTE | 676 | Q7Z589 | |
| SNTQKITNRDSVEGV | 5591 | Q8NDH2 | |
| TTASENTEITSERQK | 716 | Q96T23 | |
| AQEVLSTTSRQISQE | 156 | Q6AZY7 | |
| RSVSEKTAQIINTQD | 1256 | Q02224 | |
| VKQVTYVRNTSSEQE | 1271 | Q13233 | |
| KDTQRTITNVSDEVS | 321 | Q8N3S3 | |
| TQTEELNKQVVSSSE | 291 | O76011 | |
| DTTVGTLSQRITNQV | 181 | P51665 | |
| EIRKIQTTTTTQAVQ | 1276 | Q8NFP9 | |
| ENTSTLQRKTVQSQI | 636 | Q96QT6 | |
| TVQSTEKQEQRNSII | 606 | Q9UNA1 | |
| ESSQVSLNVTRQKTE | 271 | Q5T5J6 | |
| TSQKFVQETELSQRI | 481 | Q6IBW4 | |
| SVSSQTITKENNRNV | 51 | Q8ND24 | |
| VQLNTEDTVNTKSVN | 666 | Q5W0Q7 | |
| IRVTQNSSAEKVQTQ | 876 | Q8NDV3 | |
| QATTEKSQRIETVLQ | 181 | Q9UNN4 | |
| SEQSVSIQVRTSKGN | 81 | Q7Z340 | |
| IIQDTTNSKTVNERI | 46 | Q96K76 | |
| NVTVSQSTTVVNGRT | 2576 | Q9P273 | |
| ENPQRESSSSKTVVQ | 661 | Q6AHZ1 | |
| KTERTIQQNITEQAS | 711 | Q96JH7 | |
| KTLSSRQVVESVGNQ | 86 | Q9BVS4 | |
| DKSDVQNTQLTVETT | 1391 | Q7Z4N2 | |
| VITNSNTSTQERVEL | 116 | Q9BY31 | |
| GSVSTLTIQRTQQED | 91 | A0A1B0GXF2 | |
| TSNVAISVDQRQVKT | 311 | Q8IYM9 | |
| VSTSSQESKTTNVRQ | 131 | Q6PJT7 | |
| TPSQTKVENSNTVRT | 781 | Q14202 |